concluded U.S. Supreme Court

U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine

U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine
Details
Videos
Articles
Press
Documents
Resources
Profiles

Summary

By eliminating necessary safeguards for pregnant girls and women who undergo the dangerous mifepristone abortion drug regimen, the U.S. Food and Drug Administration failed to abide by its legal obligations to protect the health, safety, and welfare of girls and women.

Related Articles

FDA Avoids Accountability After Supreme Court Ruling
FDA Avoids Accountability After Supreme Court Ruling
Nov 18, 2022
Read More
Court Deals Blow to Lawsuit from Abortion Drug Manufacturer
Court Deals Blow to Lawsuit from Abortion Drug Manufacturer
Apr 5, 2023
Read More
YouTube Corrects Abortion Disclaimer After ADF, State AGs Set the Record Straight
YouTube Corrects Abortion Disclaimer After ADF, State AGs Set the Record Straight
Mar 22, 2024
Read More
The FDA Fails Its Own Drug Test
The FDA Fails Its Own Drug Test
Mar 7, 2024
Read More

Press Releases

FDA’s recklessness continues for now

June 13, 2024

FDA’s recklessness continues for now
US Supreme Court to hear arguments Tuesday about the FDA’s recklessness

March 25, 2024

US Supreme Court to hear arguments Tuesday about the FDA’s recklessness
ADF joins members of Congress at press conference Thursday

March 20, 2024

ADF joins members of Congress at press conference Thursday
ADF to FDA: Women deserve better

March 15, 2024

ADF to FDA: Women deserve better
Broad support to protect women’s health filed at US Supreme Court

March 4, 2024

Broad support to protect women’s health filed at US Supreme Court
FDA endangered women’s health by removing key safeguards for high-risk abortion drugs

February 22, 2024

FDA endangered women’s health by removing key safeguards for high-risk abortion drugs
Biden admin defends FDA’s reckless betrayal of women, girls

January 24, 2024

Biden admin defends FDA’s reckless betrayal of women, girls
District court grants states’ request to hold FDA accountable for removing critical safety standards for women and girls

January 12, 2024

District court grants states’ request to hold FDA accountable for removing critical safety standards for women and girls
US Supreme Court to hear case on chemical abortion drugs

December 13, 2023

US Supreme Court to hear case on chemical abortion drugs
ADF to Supreme Court: Deny Biden admin’s request to remove safeguards for chemical abortion drugs

November 9, 2023

ADF to Supreme Court: Deny Biden admin’s request to remove safeguards for chemical abortion drugs
MO, KS, ID seek to join lawsuit to restore safeguards to chemical abortion drugs

November 6, 2023

MO, KS, ID seek to join lawsuit to restore safeguards to chemical abortion drugs
ADF to US Supreme Court: Keep safeguards in place for chemical abortion drugs

October 13, 2023

ADF to US Supreme Court: Keep safeguards in place for chemical abortion drugs
FDA must restore vital safeguards for chemical abortion drugs, 5th Circuit rules

August 16, 2023

FDA must restore vital safeguards for chemical abortion drugs, 5th Circuit rules
Unlawful FDA approval of chemical abortion drugs before 5th Circuit

May 16, 2023

Unlawful FDA approval of chemical abortion drugs before 5th Circuit
Lawsuit challenging illegal approval of abortion drugs continues

April 21, 2023

Lawsuit challenging illegal approval of abortion drugs continues

Case Documents

Court
Title
Date
Trial Court
Private Plaintiff’s Notice of Voluntary Dismissal Without Prejudice
11/19/2024
U.S. Supreme Court
Supreme Court Opinion
06/13/2024
U.S. Supreme Court
Merits amicus briefs filed in support of Alliance for Hippocratic Medicine, et al.
02/26/2024
U.S. Supreme Court
Brief for the respondents
02/22/2024
Trial Court
District court order granting Missouri, Kansas, and Idaho’s motion to intervene
01/12/2024
U.S. Supreme Court
U.S. Supreme Court orders list granting Food and Drug Administration’s and Danco Laboratories’ petitions for certiorari and denying Alliance for Hippocratic Medicine’s cross-petition
12/13/2023
U.S. Supreme Court
Respondents’ brief in opposition
11/09/2023
Trial Court
The states of Missouri, Kansas, and Idaho’s proposed complaint
11/03/2023
Trial Court
The states of Missouri, Kansas, and Idaho’s suggestions in support of their motion to intervene
11/03/2023
Trial Court
The states of Missouri, Kansas, and Idaho’s motion to intervene
11/03/2023
U.S. Supreme Court
Conditional cross-petition for a writ of certiorari
10/13/2023
Appellate Court
U.S. Court of Appeals for the 5th Circuit opinion
08/16/2023
Appellate Court
Brief of Appellees
05/08/2023
U.S. Supreme Court
U.S. Supreme Court order granting application to stay
04/21/2023
U.S. Supreme Court
Supreme Court Order Extending Stay – DOJ
04/19/2023
U.S. Supreme Court
Supreme Court Order Extending Stay – Danco
04/19/2023
U.S. Supreme Court
Opposition to application to stay or vacate injunction pending appeal
04/18/2023
U.S. Supreme Court
U.S. Supreme Court order granting administrative stay (Danco Laboratories)
04/14/2023
U.S. Supreme Court
U.S. Supreme Court order granting administrative stay (U.S. Department of Justice)
04/14/2023
U.S. Supreme Court
Danco Laboratories’ emergency application for stay of preliminary injunction pending appeal
04/14/2023
U.S. Supreme Court
U.S. Department of Justice’s application to stay the order by the U.S. District Court for the Northern District of Texas and for an administrative stay
04/14/2023
Appellate Court
U.S. Court of Appeals for the 5th Circuit order
04/12/2023
Appellate Court
Plaintiffs-appellees’ motion to dismiss
04/11/2023
Appellate Court
Plaintiffs’ opposition to an emergency stay pending appeal
04/11/2023
Appellate Court
Danco Laboratories’ emergency motion for a stay pending appeal
04/10/2023
Appellate Court
U.S. Department of Justice’s emergency motion for a stay pending appeal
04/10/2023
Trial Court
Opinion and order on motion for preliminary injunction
04/07/2023
Trial Court
Appendix in support of plaintiffs’ reply brief in support of their motion for preliminary injunction
02/24/2023
Trial Court
Plaintiffs’ reply brief in support of their motion for preliminary injunction
02/24/2023
Trial Court
Amicus Brief – Human Coalition
02/10/2023
Trial Court
Amicus Brief – The State of Missouri
02/10/2023
Trial Court
Amicus Brief – American Center for Law and Justice
02/10/2023
Trial Court
Amicus Brief – Susan B. Anthony Pro-Life America
02/10/2023
Trial Court
Amicus Brief – Life Collective
02/10/2023
Trial Court
Amicus Brief – Judicial Watch
02/10/2023
Trial Court
Amicus Brief – Texas Business Leaders
02/10/2023
Trial Court
Amicus Brief – Family Research Council
02/10/2023
Trial Court
Amicus Brief – Ethics and Public Policy Center
02/10/2023
Trial Court
Amicus Brief – Concerned Women For America
02/10/2023
Trial Court
Amicus Brief – Charlotte Lozier Institute
02/10/2023
Trial Court
Amicus Brief – Advancing American Freedom
02/10/2023
Trial Court
Amicus Brief – 67 Members of Congress
02/10/2023
Trial Court
Amicus Brief – 22 States In Support of Plaintiffs
02/10/2023
Trial Court
District court order granting Danco motion to intervene
02/06/2023
Trial Court
Declaration of Jason Lindo
01/13/2023
Trial Court
Danco Laboratories unopposed motion for leave to intervene
01/13/2023
Trial Court
Defendants’ opposition to plaintiffs’ motion for a preliminary injunction
01/13/2023
Trial Court
Amicus Brief – Chattanooga National Memorial For The Unborn
01/09/2023
Trial Court
Appendix in support of motion for preliminary injunction
11/18/2022
Trial Court
Plaintiffs’ brief in support of their motion for preliminary injunction
11/18/2022
Trial Court
Plaintiffs’ motion for preliminary injunction
11/18/2022
Trial Court
Complaint
11/18/2022

Additional Resources

One-page summary

FDA Polling

Case Profiles

Erin Morrow Hawley

Erin Morrow Hawley

Senior Counsel, Vice President of the Center for Life & Regulatory Practice

View Profile

Erik Baptist

Erik Baptist

Senior Counsel, Director of the Center for Life

View Profile

To top